CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer

Published:2019-06-04 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Racioppi Luigi^ORCID,Nelson Erik R.^ORCID,Huang Wei,Mukherjee Debarati,Lawrence Scott A.,Lento William,Masci Anna Maria^ORCID,Jiao Yiquin,Park Sunghee,York Brian,Liu Yaping,Baek Amy E.,Drewry David H.^ORCID,Zuercher William J.^ORCID,Bertani Francesca R.^ORCID,Businaro Luca^ORCID,Geradts Joseph,Hall Allison,Means Anthony R.,Chao Nelson,Chang Ching-yi^ORCID,McDonnell Donald P.^ORCID

Funder

Susan G. Komen

United States Department of Defense | United States Army | U.S. Army Corps of Engineers

U.S. Department of Health & Human Services | National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-10424-5.pdf

Reference69 articles.

1. Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49–61 (2014).

2. Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39–51 (2010).

3. Ruffell, B. et al. Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell 26, 623–637 (2014).

4. Ugel, S., De Sanctis, F., Mandruzzato, S. & Bronte, V. Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages. J. Clin. Invest. 125, 3365–3376 (2015).

5. Solinas, G., Germano, G., Mantovani, A. & Allavena, P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 86, 1065–1073 (2009).

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells;Cancer Letters;2024-08

2. Mechanistic insights into cisplatin response in breast tumors: Molecular determinants and drug/nanotechnology-based therapeutic opportunities;Mutation Research - Reviews in Mutation Research;2024-07

3. Upregulation, Functional Association, and Correlated Expressions of TRPV1 and TRPA1 During Telmisartan-Driven Immunosuppression of T Cells;Immunological Investigations;2024-04-07

4. Accelerated intestinal wound healing via dual electrostimulation from a soft and biodegradable electronic bandage;Nature Electronics;2024-03-29

5. The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer;Frontiers in Immunology;2024-02-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3